(Q39761178)

14 September 2017

Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides (English)

1 reference

14 September 2017

5

Roger Y Tsien

1 reference

14 September 2017

Todd A Aguilera

1

1 reference

14 September 2017

Emilia S Olson

series ordinal

2

1 reference

14 September 2017

Margaret M Timmers

series ordinal

3

1 reference

14 September 2017

Tao Jiang

series ordinal

4

1 reference

14 September 2017

11 May 2009

1 reference

14 September 2017

1 reference

14 September 2017

1

1 reference

14 September 2017

5-6

1 reference

14 September 2017

371-381

1 reference

Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?".

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

In vivo protein transduction: delivery of a biologically active protein into the mouse

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Is VP22 nuclear homing an artifact?

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1039%2FB904878B

Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Novel Tat-Peptide Chelates for Direct Transduction of Technetium-99m and Rhenium into Human Cells for Imaging and Radiotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A proapoptotic peptide for the treatment of solid tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1039/B904878B

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

20023744

1 reference